BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8657171)

  • 1. The 4th International Conference on Mechanisms of Antimutagenesis and Anticarcinogenesis. Banff, Canada, 4-9 September 1994.
    Mutat Res; 1996 Feb; 350(1):1-294. PubMed ID: 8657171
    [No Abstract]   [Full Text] [Related]  

  • 2. The 4th International Conference on Mechanisms of Antimutagenesis and Anticarcinogenesis: a summary.
    Liviero L; von Borstel RC
    Mutat Res; 1996 Feb; 350(1):287-93. PubMed ID: 8657193
    [No Abstract]   [Full Text] [Related]  

  • 3. Third International Conference on Mechanisms of Antimutagenesis and Anticarcinogenesis.
    De Flora S; Bronzetti G; Weisburger JH
    Cancer Epidemiol Biomarkers Prev; 1991; 1(1):95-9. PubMed ID: 1688263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synopsis of the first International Conference on Antimutagenesis and Anticarcinogenesis: mechanisms.
    Shankel DM; Hartman PE; Kada T; Hollaender A
    Environ Mutagen; 1987; 9(1):87-103. PubMed ID: 3100291
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings of the International Symposium on Antimutagenesis and Anticarcinogenesis. April 25-26, 2002, Valhalla, New York, USA.
    Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S1-108. PubMed ID: 12725235
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms of antimutagenesis and anticarcinogenesis: role in primary prevention.
    De Flora S; Izzotti A; Bennicelli C
    Basic Life Sci; 1993; 61():1-16. PubMed ID: 8304921
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanistic approaches to chemoprevention of mutation and cancer.
    Ferguson LR; Bronzetti G; De Flora S
    Mutat Res; 2005 Dec; 591(1-2):3-7. PubMed ID: 16095634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5th International Conference on Mechanisms of Antimutagenesis and Anticarcinogenesis.
    Hayatsu H; Negishi K
    Mutat Res; 1998 Jun; 402(1-2):1-5. PubMed ID: 9729133
    [No Abstract]   [Full Text] [Related]  

  • 9. [The modifications of mutagenesis and anticarcinogenesis].
    KhudoleÄ­ VV
    Vestn Ross Akad Med Nauk; 1993; (1):34-41. PubMed ID: 7682121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antievolutionary component of antimutagenesis and anticarcinogenesis: where do mutation rates come from and where are they going?
    Drake JW
    Mutat Res; 1996 Feb; 350(1):5-8. PubMed ID: 8657196
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings of the 3rd International Conference on Mechanisms of Antimutagenesis and Anticarcinogenesis. Lucca, Italy, May 5-10, 1991.
    Basic Life Sci; 1993; 61():1-494. PubMed ID: 7905731
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent developments in antimutagenesis and anticarcinogenesis.
    Levin M
    Drugs Today (Barc); 2002 Jul; 38(7):495-9. PubMed ID: 12582466
    [No Abstract]   [Full Text] [Related]  

  • 13. Antimutagenesis and anticancer effects.
    Bronzetti G; Della Croce C; Aretini P; Fiorio R
    J Environ Pathol Toxicol Oncol; 1996; 15(2-4):59-64. PubMed ID: 9216786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-dependent mutagenesis and cancer: a new role for antimutagenesis in cancer prevention?
    MacPhee DG
    Mutat Res; 1998 Jun; 402(1-2):29-39. PubMed ID: 9675238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimutagenesis/anticarcinogenesis 2001: mechanistic studies.
    Gentile JM; Gentile G; Lohman PH; Ferguson LR
    Mutat Res; 2001 Sep; 480-481():1-7. PubMed ID: 11506794
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimutagenesis and anticarcinogenesis, from the past to the future.
    Weisburger JH
    Mutat Res; 2001 Sep; 480-481():23-35. PubMed ID: 11506796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimutagenesis/anticarcinogenesis 2001: screening, methods and biomarkers.
    Lohman PH; Gentile JM; Gentile G; Ferguson LR
    Mutat Res; 2001 Sep; 496(1-2):1-4. PubMed ID: 11551474
    [No Abstract]   [Full Text] [Related]  

  • 18. [Carcinogenic mechanisms and anticarcinogenesis].
    KavetskiÄ­ RE
    Vopr Onkol; 2005; 51(6):632-5. PubMed ID: 17037026
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple drug resistance, antimutagenesis and anticarcinogenesis.
    Ferguson LR; De Flora S
    Mutat Res; 2005 Dec; 591(1-2):24-33. PubMed ID: 16087200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings of the 4th International Conference on Anticarcinogenesis and Radiation Protection. Baltimore, Maryland, April 18-23, 1993.
    Cancer Res; 1994 Apr; 54(7 Suppl):1875s-2053s. PubMed ID: 7907947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.